No abstract available
Keywords:
activated oncogene; diagnosis; oncogenic viruses; prognosis; therapy; tumor; tumor suppressor gene.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The works of the authors were supported, in part, by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) grant IG 21617 (to MT), University of Ferrara, Fondo di Ateneo per la ricerca (FAR) grants 2022 and MUR PRIN 2017 (to FM), AIRC grant MF 21956 (to JCR), FFARB from MIUR (to GF). JCR was supported by Umberto Veronesi Foundation with a ‘Post-doctoral Fellowship 2023’.